Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

Abstract

The European Vasculitis Study Group undertook a controlled trial of 149 patients randomised to receive a consensus - designed pulse cyclophosphamide regimen or a DO cyclphosphamide regimen.

Keywords

• EUVAS
• cyclopghosphamide
• granulomatosis
• microscopic polyangiitis